Pharma Journalist - Page 28 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Lupin Wins FDA Approval for Armlupeg Pegfilgrastim Biosimilar

Regeneron, Tessera Partner on Gene Writing Therapy for AATD

Lotus Files South Korea NDA for LENZ’s Presbyopia Drug VIZZ

FDA Grants Rare Pediatric Disease Status to Solid Biosciences’ FA Therapy

Final Days to Save £200 on AI in Drug Discovery 2026 Registration – Offer Ends 5 December

Telix Opens First APAC Radiopharmaceutical Manufacturing Site in Japan

Made Scientific, Cellergy Partner to Advance First Mitochondrial Therapy

Novo Nordisk Alzheimer’s Trials Show No Benefit for Semaglutide

FDA Approves First Gene Therapy for Broad SMA Patient Population

Vaximm Enters Talks for Global License of Oral Cancer Therapy